INTRODUCTION
Dominant alleles of the agouti locus induce most notably a yellow coat color in the mouse, whereas the most dominant mutations (e.g. A y or A vy ) produce additional phenotypic changes including adult-onset obesity, increased linear growth, and hyperinsulinemia (for review, see Refs. 1 and 2). The cloning of the murine agouti gene (3) predicts a 108-amino acid secreted protein that is normally expressed in skin during postnatal days 3 to 5, corresponding to the time during which pheomelanin deposition occurs in the developing hair shaft. In contrast, the dominant lethal yellow (A y ) allele of agouti results in constitutive and ubiquitous expression of agouti-signaling protein (ASP) as a consequence of a promoter rearrangement (4) . The obesity and coat color phenotypes of the A y animal are recapitulated by transgenic mice having a ␤-actin promoter driving ubiquitous ASP expression (5) . However, transgenic mice using a keratin-14 promoter to direct skin-specific expression of ASP have only the yellow coat color phenotype, demonstrating that agouti acts locally in a paracrine manner (6) and that expression outside of the skin is required for the induction of obesity.
Experiments by Lu et al. (7) demonstrated that ASP is a competitive antagonist of the melanocortin-1 re-ceptor expressed in skin melanocytes (8, 9) . The melanocortin-1 receptor is normally stimulated by ␣-MSH to increase intracellular cAMP levels, inducing tyrosinase activity, and eumelanin or brown/black pigment synthesis. One hypothesis for the nonpigmentary phenotypes seen in A y mice is that aberrant expression of ASP in the central nervous system antagonizes related hypothalamic melanocortin receptors (7) . This model was originally proposed based upon evidence that ASP is also a competitive antagonist of the highly related melanocortin-4 receptor (MC4-R) (7), which is expressed in regions of the hypothalamus important for the control of feeding behavior (10) . Strong support for this model comes from two recent studies. First, central administration of the ␣-MSH analog SHU9119, a high-affinity antagonist of the neural MC3 and MC4 receptors, significantly stimulates feeding in mice, whereas an agonist potently inhibited feeding in several murine models of hyperphagia (11) . Second, ablation of functional MC4 receptors by targeted disruption of the MC4-R gene in mice recapitulates several aspects of the agouti obesity syndrome (12) .
One possible effect of losing MC4-R activity, either by genetic deletion or chronic antagonism by ASP, may be perturbation of normal hypothalamic signaling. Neuropeptide Y (NPY) (13) and galanin (14) are two neuropeptides present in high concentrations in the hypothalamus that, when injected into the brain, stimulate feeding. Recent experiments have shown that hypothalamic NPY levels are elevated in other models of rodent obesity, including the ob/ob mouse (15) and the Zucker fatty rat (16) , as well as in streptozocininduced diabetic rats (17) and in mice given hypothalamic lesions via gold-thioglucose treatment (18) . Therefore it seemed possible that NPY or possibly galanin synthesis may be stimulated in A y or MC4-R deficient mice. Alternatively, melanocortinergic neurons may respond to loss of normal MC4-R function by compensatory changes in the synthesis of the melanocortin ligands encoded by the preprohormone gene POMC. In this report, NPY, galanin, and POMC gene expression were examined as a function of the A y or MC4-RKO obesity syndromes. tensely labeled neurons in the DMH was identified (with minor labeling of the lateral hypothalamic area), whereas hypothalamic expression of NPY in the ob/ob mouse was restricted to the ARC only. No comparable differences in either galanin (middle) or POMC (bottom) mRNA expression levels were observed between the C57, A y , and ob/ob mice (Fig. 1) .
RESULTS

NPY Gene Expression but
Elevated DMH NPY Gene Expression Is Associated with the Obese State in Lethal Yellow
To determine whether expression of NPY in the DMH is constitutive or coincident with the development of obesity in the A y mouse, developmental expression of NPY was examined. Figure 2 displays representative dark-field photomicrographs of coronal hypothalamic sections (mid-DMH level) of young nonobese (3 wk, 15 g), adult nonobese (12 wk, 28 g), and adult obese (6 mo, 55 g) A y mice (panels A, B, and C, respectively) after in situ hybridizations with a NPY probe. Note that in the adult nonobese A y animal (12 wk, 28 g), NPY expression is restricted primarily to the ARC, whereas the obese (55 g) A y animal expresses NPY in both the ARC and the DMH. In contrast, ARC neurons in the obese ob/ob (58 g) animal (Fig. 2D ) have a readily discernible greater density of silver grains per cell as well as a greater number of cells expressing NPY when compared with the A y animals ( Fig. 2 , A-C). However, virtually no cells in the DMH express NPY in the ob/ob animal, but numerous cells in this brain region express high levels of NPY mRNA in the obese A y mouse. NPY expression in the ARC and DMH was evaluated semiquantitatively in C57, A y , and ob/ob mice. Hybridization signals over the ARC and DMH in these animals indicate that although there is no measurable difference in NPY expression in the ARC of A y animals, NPY mRNA levels are elevated more than 50% in ob/ob mice, when compared with C57 control animals (Fig.  3, left) . In the DMH, only obese A y animals display elevated NPY mRNA expression levels, when compared with that seen in C57 controls, ob/ob, or nonobese A y mice (Fig. 3, right) .
MC4 Receptor-Deficient Mice Display Elevated NPY Gene Expression in the DMH
As seen in the autoradiogram in Fig. 4 , in situ hybridizations of coronal brain sections from MC4-R-deficient mice using a NPY antisense probe demonstrated that elimination of this melanocortin receptor by targeted disruption of the MC4-R gene (12) leads to increased expression of NPY in the DMH. Female homozygous (Ϫ/Ϫ) MC4-R deficient mice (bottom), display intense hybridization of the NPY probe over the DMH, whereas heterozygous (Ϯ) mice (middle) with one functional MC4-R allele, and wild type (ϩ/ϩ) control mice (upper), display labeling for NPY over the ARC only. Similar results were seen in comparable male animals (data not shown).
DISCUSSION
The results obtained in these experiments demonstrated no major changes in hypothalamic gene expression of galanin or POMC in the three genetic models of murine obesity examined (A y , MC4-R knockout, and ob/ob) when compared with controls. In contrast to the similar expression patterns seen for galanin and POMC, the distribution of hypothalamic NPY mRNA expression in mice with melanocortinergic obesity syndrome was dramatically different from control and leptin-deficient mice. Previous experiments have demonstrated that ARC NPY levels are elevated in several models of rodent obesity. In rats, for instance, the genetically obese Zucker fatty strain has elevated ARC NPY mRNA levels when compared with lean littermates (16) , and, similarly, streptozocin-induced diabetic rats display increased ARC NPY gene expression (17) . In mice, hypothalamic lesions induced by goldthioglucose treatment result in nearly a 50% increase in ARC NPY expression (18) , whereas in the genetically obese ob/ob mouse, Northern analysis demonstrated hypothalamic NPY mRNA to be elevated more than 3-fold (15) . In contrast, NPY mRNA levels in the ARC of both A y and MC4-R deficient mice were normal when compared with wild type mice. Surprisingly, however, obese A y mice as well as MC4-R-deficient mice displayed a large induction of NPY gene expression in another hypothalamic nucleus, the DMH.
In the present experiments, both male and female A y mice weighing more than 55 g exhibited elevated NPY mRNA expression in DMH neurons; younger A y mice weighing less than 30 g displayed normal hypothalamic NPY expression in ARC neurons and no expression in the DMH (Fig. 2) . Furthermore, nonobese mice that have a single functional MC4-R allele (heterozygous MC4-R knockout) do not express NPY aberrantly. The expression of NPY in the DMH is not associated with all models of obesity, however, because obese ob/ob mice did not display any detectable NPY expression in the DMH. Therefore, activation of NPY expression in DMH neurons is correlated specifically with the melanocortinergic obesity syndromes that derive from a loss of MC4-R activity.
Expression of NPY mRNA in the DMH has not been reported previously in other mouse or rat models of obesity; however, there are some reports of altered NPY peptide levels in this nucleus associated with feeding status (19) (20) (21) . In these experiments, fluctuations in NPY peptide levels in the DMH are probably reflecting the activation of NPY-ergic neurons that originate in the ARC and project to the DMH (22) . Interestingly, the only reported activation of NPY-ergic neurons originating in the DMH is in lactating rats that also display a characteristic elevation of NPY mRNA in the DMH nucleus (23) in response to suckling, which may reflect an activation of a feeding pathway in response to an increased nutritional need.
A simplified model proposing a role for NPY in both the ob/ob and melanocortinergic obesity models is shown schematically in Fig. 5 . The disruption of leptin signaling in the ob/ob or db/db mouse results in an elevation of NPY gene expression in the ARC, perhaps directly via leptin receptors in the ARC. This enhanced release of NPY is responsible for a significant portion of the phenotype in the ob/ob animal, as supported by recent observations on attenuation of the obesity syndrome by deletion of the NPY gene from the ob/ob mouse (24) .
It is further proposed that des-acetyl-␣-MSH, released at MC4-R-containing synapses in the DMH, is normally inhibitory of NPY gene expression in this nucleus. However, when MC4-R activity is suppressed or absent, due to either chronic antagonism by ectopically expressed agouti (4) or genetic deletion of the MC4-R (12), NPY synthesis eventually becomes elevated in DMH neurons. In the melanocortinergic obesity syndrome, the presumed enhanced release of NPY by DMH neurons projecting to the paraventricular hypothalamic nucleus (PVN) then provides a stimulatory input to feeding behavior. The absence of NPY gene expression in the DMH in young A Y animals indicates that abrogation of melanocortinergic signaling alone is not sufficient for the induction of this change. The identification of this discrete gene expression change in the A y and MC4-RKO obesity models also provides further support for the idea that ectopic expression of ASP and deletion of the MC4-R cause an obesity syndrome via the same central mechanism. Although this model proposes the most simplistic view by which NPY gene expression is altered, it is of course possible that many intermediate steps remain to be discovered.
Induction of NPY in the DMH is clearly an informative marker of the melanocortinergic obesity syndromes and identifies the DMH as a possible downstream target of POMC neurons in their effects on feeding and metabolism. Although NPY gene induction does not appear to precede obesity in the A y model, it may be an etiological factor in melanocortinergic obesity models. Support for this comes from several lines of research. First, although POMC neurons within the ARC project throughout the brain, immunostaining with an antibody directed to ␣-MSH shows that a major projection of arcuate POMC neurons is to the DMH. Second, in situ hybridization studies have demonstrated that one of the major sites of MC4-R expression is in the anterior part of the DMH (10) . Moreover, recent experiments by Thompson et al. (25) indicate that DMH neurons project primarily within the hypothalamus, with direct innervation of the PVN, known to express NPY5 receptors (26) . However, whether the DMH neurons that project to the PVN and release NPY also express MC4 receptors is unknown.
While deletion of the NPY gene does not produce an overt feeding behavior disorder (27) , genetic crossing of NPY deficiency into leptin-deficient mice attenuates the hyperphagia of ob/ob mice approximately 50%, demonstrating a role for elevated NPY in the pathophysiology of obesity resulting from the absence of leptin (24) . We propose that a component of the hyperphagia, altered metabolism, increased linear growth, or reduced fertility seen in melanocortinergic obesity syndromes may be due to altered function of the DMH, and perhaps specifically due to elevated release of DMH-derived NPY at the PVN. Ultimately, deletion of the NPY gene from the A Y mouse may be used to determine the role of elevated NPY expression in the melanocortinergic obesity syndrome.
MATERIALS AND METHODS
Animals
Control C57Bl/6J mice, C57Bl/6J-A y heterozygous mice, and C57Bl/6J-Lep ob mice were maintained under a 12-h light, 12-h dark cycle at constant temperature, and provided food (Purina mouse chow) and water ad libitum. C57Bl/6J-A y mice in groups of three animals each consisting of young nonobese (3 wk, 15-17 g), adult nonobese (12 wk, 25-28 g), and adult obese (6 mo, 55-62 g) mice were compared with aged matched control C57Bl/6J mice (15-45 g, one to three animals each), and three obese C57Bl/6J-Lep ob mice (6 mo, 58-60 g). Anesthetized (avertin) animals were killed between 1500 and 1700 before lights out via cardiac puncture and perfused with saline (20 ml) and then 50 ml of ice-cold fixation buffer (4% paraformaldehyde in borate buffer, pH 9.5). Whole brains were rapidly removed and then postfixed overnight in 10% sucrose/fixative buffer. Blocked hypothalamic sections were frozen in powdered dry ice and then stored at Ϫ80 C until sectioned. A detailed description of the MC4-R gene deletion mouse is described by Huszar et al. (12) . For the MC4-R deletion studies, littermates consisting of a male and a female mouse from each genotype, homozygous (Ϫ/Ϫ) MC4-R-deficient (55-60 g), heterozygous (Ϯ), and homozygous (ϩ/ϩ) wild type (25-30 g) were treated as above.
In Situ Hybridization
Probe Synthesis. Antisense NPY was prepared by linearizing the plasmid pBLNPY-1, which contains 511 bp of the rat NPY gene (kindly provided by Dr. Susan Smith) with FspI. Antisense POMC was prepared by linearizing the plasmid mPOMCE3ribo with NcoI, which contains exon 3 of the mouse POMC gene (kindly provided by Dr. Malcolm Low). Antisense galanin was prepared from a 680-bp rat galanin cDNA plasmid provided by Dr. Robert Steiner, after HindIII linearization. [
35 S]cRNA probes were prepared by transcrib- Fig. 3 . NPY mRNA Levels in the ARC (left) and DMH (right) of C57BL/6J, C57BL/6J-Lep ob , C57BL/6J-A y Nonobese, and C57BL/6J-A y Obese Mice In the ARC, NPY mRNA levels of leptin-deficient (C57BL/ 6J-Lepob) mice, but not C57BL/6J-A y animals, were significantly elevated as compared with C57BL/6J control mice (P Ͻ 0.03). In the DMH, measurable NPY mRNA levels above background were found only in obese C57BL/6J-A y mice, which is highly significant when compared with C57BL/6J control mice (P Ͻ 0.0001). Absorbancies (relative NPY signal intensity) of the autoradiographic images on Cronex x-ray film were measured as described (see Materials and Methods) and analyzed using GraphPad Prism software. Hypothalamic brain blocks were mounted on a frozen stage and serially sectioned into four series of 20-m slices with a sliding microtome. Sections were prepared and processed for in situ hybridization as previously described (18) .
Sections were hybridized for 20 h at 58 C with 35 S-labeled probes (5 ϫ 10 6 cpm/ml in 65% formamide, 0.26 M NaCl, 1.3ϫ Denhardt's solution, 1.3 mM EDTA, 13% dextran sulfate, 13 mM Tris, pH 8). Sections were then digested with RNase (20 g/ml) for 30 min at 37 C and then desalted in a series of washes from 4ϫ SSC (0.15 M NaCl, 0.1 M Na 3 C 6 H 5 O 7 ⅐2 H 2 O) 1 mM dithiothreitol to a final stringency of 0.1ϫ SSC/1 mM dithiothreitol at 65 C for 30 min. Sections were dehydrated in ascending ethanol, vacuum dried at room Representative autoradiograms of coronal brain sections through the DMH are shown after in situ hybridization with prepro-NPY for wild type (ϩ/ϩ), heterozygous MC4-R deficient (Ϯ), and homozygous MC4-R deficient (Ϫ/Ϫ) mice in panels A, B, and C, respectively. Hypothalamic expression of NPY is restricted to the ARC in the nonobese wild type and heterozygous MC4-R-deficient mice.
temperature for 30 min, and then exposed to Dupont Cronex film (Dupont, Wilmington, DE) for several days. Dried slides were then dipped in NTB-2 emulsion (Kodak, Rochester, NY) and developed after 6 days. Quantification of Autoradiograms. The absorbancies of the autoradiographic images on Cronex x-ray film were measured by using a Macintosh-based image analysis system and NIH Image software obtained from NIH. The film was illuminated with a ChromaPro 45 light source, which provided even illumination, and the image was captured with a Dage MTI 70 series video camera equipped with a Newvicon tube and interfaced with a Scion image capture board. The mean absorbancies of the autoradiographic images on Cronex xray film over the ARC or DMH (12 h exposure) at the same level from each brain were measured. The mean absorbance over a large irregularly-shaped region adjacent to the ARC or DMH, that did not contain specific hybridization, was also measured on each section and used to calculate mean background density, which was subtracted from the absorbance measurement of signals over the ARC or DMH. Commercially available 14 [C] autoradiographic standards were exposed to each x-ray film along with experimental material. The mean absorbance of an interactively defined region over each standard was measured; these measurements confirmed the linearity of the film's responsiveness, as well as the consistency of signal detection across films. The mean absorbancies of the auroradiographic images recorded over the ARC or DMH all fell within the linear range of the standard values. A twoway ANOVA test was used to test for significant differences in levels of POMC, galanin, or NPY mRNA hybridization among the treatment groups in each experiment. A P value of less than 0.05 was defined as significant. 
